Get our lovely INSIGHT 2019 conference news


Email address
First Name
Last Name
Interested in InSight 2019
Cart
<We_can_help/>

What are you looking for?

<Good_things_happen/> Welcome to Conference

Speakers and Workshop Facilitators

Kim Kuypers
Dr.

Kim Kuypers

Research with psychedelics

Matthias Liechti
Prof. Dr.

Matthias Liechti

Current research on LSD in healthy subjects and patients

Thomas Metzinger
Prof. Dr.

Thomas Metzinger

Rational, evidence-based enculturation of psychedelic experiences

Henrik Jungaberle
Dr. sc. hum

Henrik Jungaberle

The Re-Evaluation of Psychedelics

Franz X. Vollenweider
Prof. Dr. med.

Franz X. Vollenweider

tba

Gerhard Gründer
Prof. Dr.

Gerhard Gründer

How do psychotropic drugs work?

Matthew Johnson
MD

Matthew Johnson

Therapeutic effects of psilocybin

Katrin Preller
Dr.

Katrin Preller

The neurobiology and neuropharmacology of psychedelic-induced altered states of consciousness

Charles L. Raison
MD

Charles L. Raison

A new approach to treating depression; a non-profit’s role in advancing the science and regulatory path to approval for psilocybin

Sascha Benjamin Fink
Prof. Dr.

Sascha Benjamin Fink

What is a Bewusstseinskultur?

Andrea Jungaberle
Dr. med.

Andrea Jungaberle

Psychedelic states, death and dying – in emergency medicine and beyond

Chris Letheby
Dr.

Chris Letheby

Psychedelic therapy and philosophical naturalism

Peter Gasser
Dr. med.

Peter Gasser

Current research on LSD in healthy subjects and patients

Rosalind Watts
Dr.

Rosalind Watts

Accept, Connect, Embody: A Psychedelic Therapy Framework

Milan Scheidegger
MD, PhD, MA HPK

Milan Scheidegger

Psychedelic Medicines

Max Wolff
Dr.

Max Wolff

Avoidance and Acceptance in Psychedelic Therapy: A Cognitive-Behavioral Perspective

Karl-Josef-Theine
Dr. med.

Karl-Josef-Theine

Avoidance and Acceptance in Psychedelic Therapy: A Cognitive-Behavioral Perspective

Rotem Petranker
M.Sc.

Rotem Petranker

Rotem Pranker will discuss the results of his promising academic study, and the therapeutic potential of psylocybin microdosing.

Yasmin Schmid
MD

Yasmin Schmid

Acute effects of lysergic
acid diethylamide and
3,4-methylenedioxymethamphetamine in
healthy subjects and in patients during
drug-assisted psychotherapy

Lea Julia Mertens
M.Sc.

Lea Julia Mertens

Therapeutic Mechanisms of Psychedelic Drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression

Marvin Däumichen
M.A.

Marvin Däumichen

Cooperation or Competition? The future of psychedelic science in Europe

Filip Bromberg
M.Sc

Filip Bromberg

Cooperation or Competition? The future of psychedelic science in Europe

Fabian Wenner
Dr. phil.

Fabian Wenner

Psychedelika und Recht

Ingmar Gorman
PhD

Ingmar Gorman

Psychedelic Integration

Enzo Tagliazucchi
Dr.

Enzo Tagliazucchi

Natural language as a window into drug-induced altered states of consciousness

Raphaël Millière
Dr.

Raphaël Millière

Introduction to the microphenomenological interview

Marc Wittmann
Dr.

Marc Wittmann

How altered states of consciousness have a healing potential in psychiatric illness

Marco Aqil
M.Sc.

Marco Aqil

Cooperation or Competition? The future of psychedelic science in Europe

Daan van der Gouwe
M.A.

Daan van der Gouwe

tba

Vanja Palmers

Vanja Palmers

Meditation and Psychedelics

Rolf Verres
Prof. Dr. med. Dipl. Psych.

Rolf Verres

Workshop: Essential questions – Psychedelics, death and dying

Regina Hess
Dr.

Regina Hess

Introduction into BEYOND EXPERIENCE – the MIND Foundation Integration Program

Emily Hammond
M.Sc

Emily Hammond

Introduction to the microphenomenological interview

Simona Rakusa
M.A.

Simona Rakusa

Breath as a Tool for Self-Exploration

Marijan Bernardic
Dipl.-Psych.

Marijan Bernardic

Breath as a Tool for Self-Exploration

David Heuer
M.A.

David Heuer

Introduction into BEYOND EXPERIENCE – the MIND Foundation Integration Program

Hannes Kettner
M.Res

Hannes Kettner

Psychedelics in context: Psychological, social, and environmental factors in guided group experiences

Ashleigh Murphy-Beiner
Assistant Psychologist

Ashleigh Murphy-Beiner

Ashleigh Murphy-Beiner will talk about ayahuasca’s ‘afterglow’ and how it can improve cognitive flexibility and mindfulness in naïve and experienced ayahuasca drinkers

Ansgar Rougemont-Bücking
Dr. med.

Ansgar Rougemont-Bücking

What we know in 2019 about the essence of trauma and what this means for implementing the psychedelic experience in trauma therapy

Gregory Wells
PhD Psychologist

Gregory Wells

Together with his colleague Veronica Gold, Gregory Wells will talk about the phenomenology of the ketamine experience and reports from Ketamine Assisted Psychotherapy (KAP)

Elizabeth Nielson
PhD

Elizabeth Nielson

Psilocybin-assisted treatment of alcohol use disorder

Michael Koslowski
Dr. med.

Michael Koslowski

Psychedelic therapy – how much psychotherapy is part of it?

Friederike Holze
M.Sc

Friederike Holze

Direct within-subject comparison of the acute subjective and autonomic effects of LSD, MDMA, and amphetamine in healthy subjects

Lili Vasquez-Mock
Psychologist

Lili Vasquez-Mock

Breath as a Tool for Self-Exploration

Veronika Gold
MA

Veronika Gold

Together with her colleague Gregory Wells, Veronika Gold will talk about the phenomenology of the ketamine experience and reports from Ketamine Assisted Psychotherapy (KAP)

James Close
M.Sc.

James Close

Psychedelics promote psychological flexibility – Results of a prospective web-survey using the Acceptance in Action Questionnaire II

Felix Betzler
Dr. med.

Felix Betzler

Psychedelic therapy – how much psychotherapy is part of it?

Mateo Sanchez
MRes

Mateo Sanchez

Connecting People: Psychedelics, phenomenology, psychiatry, posthumanism

Roberto De Filippo
M.Sc.

Roberto De Filippo

Serotonergic modulation of network activity in mouse brain

Nicole Amada
PhD Student

Nicole Amada

Nicole Amada will present her exploratory qualitative study of psychedelic-induced identity transformations

Carla Soares
MSc

Carla Soares

Self-care Practices with Psychedelics

Prateep Beed
PhD

Prateep Beed

Serotonin and Psychedelics – what happens at the single neuron level?

Marcus Meinhardt
M.Sc.

Marcus Meinhardt

Evaluating the therapeutic potential of hallucinogens in rat models of alcohol addiction

Tharcila Chaves
PhD Candidate

Tharcila Chaves

The ketamine breakthrough: a new paradigm for the treatment of depression and pain

Patrick Vizeli
M.Sc.

Patrick Vizeli

Pharmacological and psychological predictors of the MDMA response in placebo-controlled studies in healthy subjects

Maria Balaet
PhD Student

Maria Balaet

Maria Balaet will present her poster of the impact of psychedelic drugs on memory processing

Adam Aronovich
PhD

Adam Aronovich

Ayahuasca as Relational Medicine: Intimate encounters at the frontiers of liquid modernity

Jörg-Simon Schmid
M.A.

Jörg-Simon Schmid

Integrativer Umgang mit Drogen – Jugendliche zwischen Paranoia und Spiritualität

Danny Forde
PhD

Danny Forde

How am I not myself?: The self in the psychedelic experience

Alexandra Rodrigues
MD

Alexandra Rodrigues

Dimethyltryptamine: endogenous role and therapeutic potential

Malin Vedøy Uthaug
PhD Candidate

Malin Vedøy Uthaug

A prospective examination of the effects and experiences following either vaporization or intramuscular injection of synthetic 5-methoxy-N,N-dimethyltryptamine in a naturalistic setting

Emma Chirstersson
B.Sc.

Emma Chirstersson

The Psychedelic Altered State of Consciousness: Entropic brain theory vs. Integrated information theory

Conference tickets

With your ticket you will have access to the whole conference - with keynotes, panels, round tables, posters and daylight social events. We will ask for a small extra fee for the Friday evening social program. The pre-conference workshops have to be booked separately and each workshop needs an individual ticket. By clicking on "Book now" below you also have the option to buy your workshop tickets.

*Reduced fees apply to students, cooperation partners as well as unemployed and retired individuals. Proof of status will be required.

Early bird

until 14 April 2019

  • Standard €170
  • Reduced €80*
  • MIND members Standard €100
  • MIND members Reduced €50

Regular

after 14 April 2019

  • Standard €250
  • Reduced €150*
  • MIND members Standard €180
  • MIND members Reduced €90

Philanthropist

 

  • Donate €600 or more
  • Invite a friend/colleague to be your VIP guest at the event

Get our lovely INSIGHT 2019 conference news


Email address
First Name
Last Name